Body Central (NASDAQ:
BODY) shares dipped 45.28% to $8.75 at 9:50 am. Body Central issued downbeat Q2 earnings forecast.
K-V Pharmaceutical Company (NYSE: KV-A) dropped 20.95% to $0.83. K-V Pharmaceutical reported that the US Food and Drug Administration and the Centers for Medicare & Medicaid Services both issued updated statements on Makena®.
Infinity Pharmaceuticals (NASDAQ:
INFI) shares lost 16.35% to $11.61. Infinity Pharmaceuticals stopped mid-stage trials of saridegib in chondrosarcoma and myelofibrosis
ProPhase Labs (NASDAQ:
PRPH) fell 12.50% to $0.98. ProPhase Labs' trailing-twelve-month ROE is -20.60%.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
